Related references
Note: Only part of the references are listed.Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine Resistance
Seung Young Sea et al.
INTERVIROLOGY (2014)
Randomized Trial of the Virologic Response during up to Two Years of Entecavir-Adefovir Combination Therapy in Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients
Young-Suk Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Y. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2013)
52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
Teerha Piratvisuth et al.
PLOS ONE (2013)
Entecavir plus adefovir rescue therapy for chronic hepatitis B patients after multiple treatment failures in real-life practice
Xian-Hua Xu et al.
VIROLOGY JOURNAL (2013)
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
Sang-Hoon Ahn et al.
HEPATOLOGY INTERNATIONAL (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naive patients with HBV-related decompensated cirrhosis
H. L. Y. Chan et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern
J. Inoue et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
Spilios Manolakopoulos et al.
LIVER INTERNATIONAL (2011)
De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients
Xiao-Hong Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Telbivudine A Review of its Use in Compensated Chronic Hepatitis B
Kate McKeage et al.
DRUGS (2010)
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus
A. Tamori et al.
JOURNAL OF VIRAL HEPATITIS (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
George V. Popotheodoridis et al.
LANCET INFECTIOUS DISEASES (2008)
Transplantation: Impact of pretransplant renal insufficiency
Ranjeeta Bahirwani et al.
LIVER TRANSPLANTATION (2008)
Renal Fanconi syndrome and myopathy after liver transplantation: Drug-related mitochondrial cytopathy?
Umut Selda Bayrakci et al.
PEDIATRIC TRANSPLANTATION (2008)
Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients
Nassim Kamar et al.
TRANSPLANTATION (2008)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Entecavir for the treatment of chronic hepatitis B virus infection
SJ Matthews
CLINICAL THERAPEUTICS (2006)
Lamivudine in hepatitis B-associated membranous nephropathy
S Tang et al.
KIDNEY INTERNATIONAL (2005)
Remission of hepatitis B virus-related vasculitis with lamivudine
T Sawabe et al.
ANNALS OF INTERNAL MEDICINE (2004)
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials
F Fabrizi et al.
TRANSPLANTATION (2004)
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
DS Keith et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies
H Izzedine et al.
KIDNEY INTERNATIONAL (2004)
Excellent outcome of lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection
H Schmilovitz-Weiss et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion
N Tanji et al.
HUMAN PATHOLOGY (2001)
Share Paper
